Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M88.9Revenue (TTM) $M6.3Net Margin (%)-296.7Altman Z-Score-12.3
Enterprise Value $M51.2EPS (TTM) $-0.3Operating Margin %-299.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.5Pre-tax Margin (%)-296.7Higher ROA y-yN
Price/Book3.010-y EBITDA Growth Rate %-16.4Quick Ratio4.5Cash flow > EarningsN
Price/Sales13.05-y EBITDA Growth Rate %-6.7Current Ratio4.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-43.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-56.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M71.1ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ARQL

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ARQL is held by these investors:



ARQL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LOBERG MICHAEL DDirector 2015-12-17Buy3,719$2.16-42.13view
LOBERG MICHAEL DDirector 2015-12-16Buy1,231$2.14-41.59view
Pucci PaoloCEO 2015-12-15Buy1,283$2.16-42.13view
Pucci PaoloCEO 2015-12-11Buy1,108$2.1-40.48view
ZENNER PATRICK JDirector 2015-12-11Buy2,300$2.15-41.86view
Pucci PaoloCEO 2015-12-10Buy7,609$2.1-40.48view
ZENNER PATRICK JDirector 2015-03-11Buy10,625$2.32-46.12view
Pucci PaoloCEO 2014-11-20Buy5,000$1.26-0.79view
ZENNER PATRICK JDirector 2014-11-14Buy20,830$1.24.17view
Messenger William GDirector 2014-11-14Buy8,500$1.213.31view

Quarterly/Annual Reports about ARQL:

News about ARQL:

Articles On GuruFocus.com
Jean-Marie Eveillard Increases Stakes in Cancer Therapeutics Company Arqule Inc May 05 2015 
Jean-Marie Eveillard Adds to Stake in Arqule Inc. May 03 2015 
ArQule Inc. Reports Operating Results (10-Q) Nov 09 2010 
ArQule Inc. Reports Operating Results (10-Q) Aug 04 2010 
ArQule Inc. Reports Operating Results (10-Q) May 06 2010 
ArQule Inc. (ARQL) CEO Paolo Pucci buys 5,000 Shares Nov 13 2009 
ArQule Inc. Reports Operating Results (10-Q) Aug 07 2009 
ArQule Inc. (ARQL) CEO Paolo Pucci buys 2,500 Shares May 15 2009 
ArQule Inc. Reports Operating Results (10-Q) May 08 2009 

More From Other Websites
ArQule To Report Fourth Quarter and Year End 2016 Financial Results On March 7, 2017 Feb 24 2017
ArQule Liver Cancer Drug Fails Phase 3 Trial Feb 20 2017
ArQule, Inc. (ARQL)’s Liver Cancer Drug Fails: What’s Next? Feb 20 2017
Sabre Corp., L Brands Dip into Friday’s 52-Week Low Club Feb 17 2017
ARQULE INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 17 2017
Daiichi Sankyo and ArQule Announce the Completion of the METIV-HCC Phase 3 Study of Tivantinib in... Feb 17 2017
Daiichi Sankyo and ArQule Announce the Completion of the METIV-HCC Phase 3 Study of Tivantinib in... Feb 17 2017
Daiichi Sankyo and ArQule Announce the Completion of the METIV-HCC Phase 3 Study of Tivantinib in... Feb 17 2017
ArQule to Present at The Leerink Partners 6th Annual Global Healthcare Conference on February 15,... Feb 08 2017
ArQule (ARQL) Catches Eye: Stock Moves 7.2% Higher Jan 13 2017
ARQULE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Jan 10 2017
ETFs with exposure to ArQule, Inc. : December 21, 2016 Dec 21 2016
How ArQule, Inc. (ARQL) Stacks Up Against Its Peers Dec 20 2016
Data on Proprietary BTK Inhibitor, ARQ 531, Demonstrating Inhibition of Wild Type and C481S Mutant... Dec 04 2016
Preclinical Data on Proprietary AKT Inhibitor, ARQ 092, Demonstrating Effectiveness in the Treatment... Dec 03 2016
ARQULE INC Financials Nov 16 2016
Could Trump Tax Cut Plans, Republican Congress Spur Biotech M&A? Nov 10 2016
ArQule, Inc. :ARQL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016 Nov 08 2016
Edited Transcript of ARQL earnings conference call or presentation 7-Nov-16 2:00pm GMT Nov 07 2016
ARQULE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 07 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)